Bio Selling General Administrative from 2010 to 2024

BIO Stock  USD 338.48  0.00  0.00%   
Bio Rad Selling General Administrative yearly trend continues to be very stable with very little volatility. Selling General Administrative is likely to drop to about 481.6 M. During the period from 2010 to 2024, Bio Rad Selling General Administrative quarterly data regression pattern had sample variance of 44914 T and median of  808,200,000. View All Fundamentals
 
Selling General Administrative  
First Reported
1989-06-30
Previous Quarter
194.7 M
Current Value
200.4 M
Quarterly Volatility
69.8 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 481.6 M, as well as many indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Check out the analysis of Bio Rad Correlation against competitors.

Latest Bio Rad's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Bio Rad Laboratories over the last few years. It is Bio Rad's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Bio Selling General Administrative Regression Statistics

Arithmetic Mean727,641,554
Geometric Mean637,301,925
Coefficient Of Variation29.13
Mean Deviation133,832,787
Median808,200,000
Standard Deviation211,929,342
Sample Variance44914T
Range833.6M
R-Value0.39
Mean Square Error41159.8T
R-Squared0.15
Significance0.16
Slope18,295,119
Total Sum of Squares628796.6T

Bio Selling General Administrative History

2024481.6 M
2023846.8 M
2022827.8 M
2021879.6 M
2020800.3 M
2019824.6 M
2018834.8 M

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as Selling General Administrative, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Selling General Administrative846.8 M481.6 M

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

  0.43FDMT 4D Molecular TherapeuticsPairCorr
  0.43ICU LMF Acquisition OppoPairCorr
  0.38MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.34JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.412
Earnings Share
(28.06)
Revenue Per Share
90.815
Quarterly Revenue Growth
0.028
Return On Assets
0.0186
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.